0001209191-16-090516.txt : 20160108
0001209191-16-090516.hdr.sgml : 20160108
20160108161357
ACCESSION NUMBER: 0001209191-16-090516
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160107
FILED AS OF DATE: 20160108
DATE AS OF CHANGE: 20160108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENOMIC HEALTH INC
CENTRAL INDEX KEY: 0001131324
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 770552594
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-556-9300
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vaughn James J
CENTRAL INDEX KEY: 0001649689
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51541
FILM NUMBER: 161333428
MAIL ADDRESS:
STREET 1: C/O GENOMIC HEALTH, INC.
STREET 2: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-01-07
0
0001131324
GENOMIC HEALTH INC
GHDX
0001649689
Vaughn James J
301 PENOBSCOT DRIVE
REDWOOD CITY
CA
94063
0
1
0
0
Chief Commercial Officer
Common Stock
2016-01-07
4
M
0
2000
18.89
A
26076
D
Common Stock
2016-01-07
4
S
0
2000
33.6326
D
24076
D
Employee Stock Option (right to buy)
18.89
2016-01-07
4
M
0
2000
0.00
D
2016-11-30
Common Stock
2000
4000
D
These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on September 9, 2015.
Represents weighted average sale price. Actual sale prices ranged from $33.3483 to $33.9262.
Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Includes an aggregate of 16,327 shares of common stock issuable pursuant to previously reported restricted stock units and performance-based vesting restricted stock units awards that have not vested.
The option became exercisable as to 25% of the shares on November 30, 2007, and became exercisable as to 1/48th of the shares each full month thereafter.
/s/ Jason W. Radford, Attorney-in-fact
2016-01-08